Clinical Trial Update: S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of S-1, oxaliplatin, and irinotecan for advanced gastrointestinal cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Gastrointestinal Neoplasms | Phase 1 | Status: COMPLETED